Top compounds associated with response to LMNTD2


Feature Type Standardized
Nominal ANOVA
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.081 0.02
mRNA GW843682X GDSC1000 pan-cancer AAC -0.12 0.02
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC -0.081 0.02
mRNA L-685458 CCLE pan-cancer AAC -0.11 0.02
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC 0.088 0.02
mRNA CIL55 CTRPv2 pan-cancer AAC 0.14 0.02
mRNA SR1001 CTRPv2 pan-cancer AAC 0.087 0.02
mRNA SNX-2112 GDSC1000 pan-cancer AAC -0.069 0.02
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.02
mRNA Irinotecan CCLE pan-cancer AAC -0.12 0.03
Download CSV